Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Alzheimer’s Disease
View through CrossRef
Advances in the current management and treatment of Alzheimer’s disease have grown directly from our increased understanding of the neurobiology underlying this disease. Currently available pharmacologic and nonpharmacologic treatment strategies remain focused on symptomatic management of disease rather than disease modification. Despite a wealth of evidence supporting the clinical benefits of existing therapies in the management of symptomatic progression, there is limited evidence that these available therapies modify disease progression over the course of dementia progression. More recent research discoveries in the areas of genetics, molecular and cell biology, and environmental risk factors have become the focal point for an explosive growth in experimental disease-modifying strategies designed to prevent, slow, or potentially halt the progression of Alzheimer’s disease.
Title: Alzheimer’s Disease
Description:
Advances in the current management and treatment of Alzheimer’s disease have grown directly from our increased understanding of the neurobiology underlying this disease.
Currently available pharmacologic and nonpharmacologic treatment strategies remain focused on symptomatic management of disease rather than disease modification.
Despite a wealth of evidence supporting the clinical benefits of existing therapies in the management of symptomatic progression, there is limited evidence that these available therapies modify disease progression over the course of dementia progression.
More recent research discoveries in the areas of genetics, molecular and cell biology, and environmental risk factors have become the focal point for an explosive growth in experimental disease-modifying strategies designed to prevent, slow, or potentially halt the progression of Alzheimer’s disease.
Related Results
Alzheimer's Disease (Oxford Neurology Library)
Alzheimer's Disease (Oxford Neurology Library)
Providing clinicians with the latest developments in research, this new edition of Alzheimer's Disease is a succinct and practical introduction to the diagnosis, evaluation, and ma...
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
Dementia 1: Defining Dementia, Alzheimer’s Disease and Frontotemporal Dementia (DRAFT)
The video in this chapter explores dementia, and focuses on definitions of dementia, Alzheimer’s disease and Frontotemporal Dementia. Dementia is defined as a cognitive decline in ...
Rheumatoid arthritis—management
Rheumatoid arthritis—management
Influential guidelines on rheumatoid arthritis (RA) management agree on most key recommendations. Early diagnosis of persistent synovitis, and identification of poor prognostic mar...
A History of Multiple Sclerosis
A History of Multiple Sclerosis
While we now recognize that MS is a common neurological disease, as late as the early twentieth century it was considered a relatively rare condition in Europe and the United State...
Disclosing the diagnosis of Alzheimer’s disease
Disclosing the diagnosis of Alzheimer’s disease
Diagnostic disclosure of Alzheimer’s disease is generally accepted to be good practice; however, there are important factors for clinicians to consider when preparing to impart suc...
Diagnosing Alzheimer’s disease in clinical practice
Diagnosing Alzheimer’s disease in clinical practice
The diagnostic evaluation in a patient with cognitive impairment suspected of having Alzheimer’s disease (AD) should include investigations aimed at 1) confirming and characterizin...
Diagnosing Alzheimer’s disease in clinical practice
Diagnosing Alzheimer’s disease in clinical practice
• In the current clinical criteria, the diagnosis of Alzheimer’s disease (AD) is a clinical diagnosis based on characteristic symptoms and signs, and the exclusion of other causes....
Frontotemporal dementia
Frontotemporal dementia
Frontotemporal dementia (FTD) is the second most common form of dementia in persons younger than 65 years after Alzheimer’s disease. The FTD spectrum is characterized by clinical, ...